Search Results - Diamant Thaçi

Secukinumab-induced chronic discoid lupus erythematosus by Giannis Chatzimichail, MD, Detlef Zillikens, MD, Diamant Thaçi, MD

Connect to this object online.

Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adver... by Alexander Egeberg, Denis Jullien, Kristian Gaarn Du Jardin, Diamant Thaçi

Connect to this object online.

Exploring the effect of deucravacitinib in patients with palmoplantar pustular psoriasis by David A. De Luca, Cristian Papara, Tomasz Hawro, Diamant Thaçi, Sascha Ständer

Connect to this object online.

Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network by Henner Zirpel, Ralf J. Ludwig, Henning Olbrich, Khalaf Kridin, Sascha Ständer, Diamant Thaçi

Connect to this object online.

Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials by Alexander Egeberg, Curdin Conrad, Patricia Gorecki, Sven Wegner, Jozefien Buyze, Lorenzo Acciarri, Diamant Thaçi

Connect to this object online.

No impact of disease duration on response to tildrakizumab treatment among patients with moderate‐to‐severe plaque psoriasis: Post hoc analyses from two phase 3 (reSURFACE 1 and re... by Johannes Griss, Gudrun Ratzinger, Julia‐Tatjana Maul, Wolfgang Weger, Diamant Thaçi, José Manuel Carrascosa, Constanze Jonak

Connect to this object online.

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S) by Norman Wasel, Diamant Thaçi, Lars E. French, Curdin Conrad, Yves Dutronc, Gaia Gallo, Lovisa Berggren, Jean-Philippe Lacour

Connect to this object online.

Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials by Kristian Reich, Diamant Thaçi, Georg Stingl, Jens Strodl Andersen, Line Conradsen Hiort, Michala Oron Lexner, David Winkler, Carle Paul

Connect to this object online.

Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search by Lluís Puig, Hideki Fujita, Diamant Thaçi, Min Zheng, Ana Cristina Hernandez Daly, Craig Leonardi, Mark G. Lebwohl, Jonathan Barker

Connect to this object online.

Dupilumab Demonstrates Rapid Onset of Action in Improving Signs, Symptoms and Quality of Life in Adults with Atopic Dermatitis by Matthias Augustin, Andrea Bauer, Konstantin Ertner, Ralph von Kiedrowski, Florian Schenck, Jutta Ramaker-Brunke, Sophie Möller, Anja Fait, Mike Bastian, Diamant Thaçi

Connect to this object online.

Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study by Diamant Thaçi, Christos Tziotzios, Taisuke Ito, Justin Ko, Ayşe Serap Karadağ, Hong Fang, Roger A. Edwards, Gianluca Bonfanti, Robert Wolk, Helen Tran, Ernest Law

Connect to this object online.

Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis by Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Zhen Chen, Ryan B. Thomas, Matthew P. Kosloski, Ariane Dubost-Brama, Randy Prescilla, Ashish Bansal, Noah A. Levit

Connect to this object online.

Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials by Thomas Bieber, Norito Katoh, Eric L. Simpson, Marjolein de Bruin-Weller, Diamant Thaçi, Antonio Torrelo, Angelina Sontag, Susanne Grond, Maher Issa, Xiaoyu Lu, Tracy Cardillo, Katrin Holzwarth, Jacob P. Thyssen

Connect to this object online.

Smoking does not Alter the Therapy Response to Systemic Anti-psoriatic Therapies: A Two-country, Multi-centre, Prospective, Non-interventional Study by Florian Anzengruber, Matthias Augustin, Marc A. Radtke, Diamant Thaci, Nikhil Yawalkar, Markus Streit, Kristian Reich, Mathias Drach, Christina Sorbe, Lars E. French, Ulrich Mrowietz, Julia-Tatjana Maul, Peter H. Itin, Alexander A. Navarini

Connect to this object online.

Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Stud... by Richard B. Warren, Lev Pavlovsky, Antonio Costanzo, Michael Bukhalo, Neil J. Korman, Yu-Huei Huang, Georgios Kokolakis, Andreas Pinter, Nadia Ibrahim, Yanbing Zheng, Leonidas Drogaris, Vassilis Stakias, Ahmed M. Soliman, Simone Rubant, Diamant Thaçi

Connect to this object online.

Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials by Neil J. Korman, Richard B. Warren, Jerry Bagel, April W. Armstrong, Melinda Gooderham, Bruce Strober, Diamant Thaçi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M. Kisa, Subhashis Banerjee, Andrew Blauvelt

Connect to this object online.